Intellicyt, acquired by Sartorius in 2016, is a key innovator in the field of flow cytometry. The company developed and commercialized high-throughput, multiplexed cell analysis platforms, most notably the iQue® Screener PLUS and Forecyt® software. These solutions enable researchers to rapidly acquire and analyze data from suspension cells, accelerating drug discovery, immunology research, and basic cell biology. Intellicyt's technology focuses on providing speed, miniaturization, and ease of use, allowing for more efficient screening and deeper biological insights. As part of Sartorius, Intellicyt's technologies are integrated into a broader portfolio of lab instruments and consumables, benefiting from Sartorius's global reach and R&D capabilities.
Primary research, development, and manufacturing hub for Intellicyt's iQue® flow cytometry platforms and related reagents and software. It serves as a center of excellence for high-throughput cell analysis technologies within Sartorius.
State-of-the-art laboratories and manufacturing facilities designed for advanced bioinstrumentation development and production. Includes specialized clean rooms and R&D labs.
As part of Sartorius, the culture emphasizes innovation, scientific rigor, and collaboration. The site fosters a dynamic environment focused on developing cutting-edge solutions for life science research, blending the agility of a specialized tech group with the resources of a global corporation.
The Albuquerque site is crucial for the continued innovation and production of the iQue® product line, which is a significant offering in Sartorius's bioanalytics portfolio. It represents a key R&D and manufacturing capability for advanced cell analysis.
Through its integration with Sartorius, Intellicyt's technologies and products have a significant global presence. Sartorius operates production sites and sales companies in approximately 60 countries. This global network supports the worldwide distribution, sales, technical service, and application support for the iQue® systems and associated assays, ensuring researchers across various regions have access to these advanced cell analysis tools.
9620 San Mateo Blvd NE
Albuquerque
New Mexico
USA
Address: Intellicyt's operations, sales, and support are integrated into Sartorius's global network of offices and R&D centers.
These global Sartorius locations provide regional sales, technical support, application expertise, and logistics for the entire Sartorius portfolio, including the iQue® platform and associated products.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Intellicyt' leadership includes:
Intellicyt has been backed by several prominent investors over the years, including:
Specific executive movements directly tied to the former Intellicyt entity are not publicly detailed post-acquisition. Changes occur within the broader Sartorius AG executive and divisional leadership structure. No major changes directly impacting the Lab Products & Services division (which houses Intellicyt's portfolio) have been prominently announced in the last 12 months. General Sartorius AG board stability has been observed.
Discover the tools Intellicyt uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Following its acquisition by Sartorius, employees associated with Intellicyt's operations use Sartorius corporate email addresses. The most common format for Sartorius email addresses is firstname.lastname@sartorius.com.
firstname.lastname@sartorius.com
Format
jane.doe@sartorius.com
Example
90%
Success rate
Sartorius News • October 3, 2016
Sartorius, a leading international pharmaceutical and laboratory equipment provider, today announced it has acquired U.S. based IntelliCyt Corporation, an award-winning innovator and manufacturer of novel cell screening platforms used in drug discovery....more
Sartorius News • February 27, 2023
Sartorius launched the iQue® Human T Cell Activation Cell and Cytokine Profiling Kit, enhancing its offering for immunology and immuno-oncology research by enabling simultaneous profiling of T cell activation markers and secreted cytokines in a high-throughput manner....more
Sartorius News • July 18, 2023
Sartorius announced the launch of its iQue® Human Immune Cell Pharmacodynamics Kit, designed to provide researchers with a powerful tool for assessing the effects of therapeutic candidates on human immune cell function directly from whole blood samples using the iQue® Advanced Flow Cytometry Platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Intellicyt, are just a search away.